Detalhe da pesquisa
1.
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial.
Lancet
; 395(10240): 1845-1854, 2020 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32450106
2.
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet
; 396(10249): 479-488, 2020 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32702299
3.
Immunization With a Novel Human Type 5 Adenovirus-Vectored Vaccine Expressing the Premembrane and Envelope Proteins of Zika Virus Provides Consistent and Sterilizing Protection in Multiple Immunocompetent and Immunocompromised Animal Models.
J Infect Dis
; 218(3): 365-377, 2018 07 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29617816
4.
Safety and immunogenicity of heterologous boosting with orally administered aerosolized bivalent adenovirus type-5 vectored COVID-19 vaccine and B.1.1.529 variant adenovirus type-5 vectored COVID-19 vaccine in adults 18 years and older: a randomized, double blinded, parallel controlled trial.
Emerg Microbes Infect
; 13(1): 2281355, 2024 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37933089
5.
A causal multiomics study discriminates the early immune features of Ad5-vectored Ebola vaccine recipients.
Innovation (Camb)
; 5(3): 100603, 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38745762
6.
Microparticulated Polygonatum sibiricum polysaccharide shows potent vaccine adjuvant effect.
Int J Pharm
; 652: 123802, 2024 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38218508
7.
Regulated control of virus replication by 4-hydroxytamoxifen-induced splicing.
Front Microbiol
; 14: 1112580, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36992923
8.
Effects of SARS-CoV-2 Omicron BA.1 Spike Mutations on T-Cell Epitopes in Mice.
Viruses
; 15(3)2023 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36992472
9.
A seroepidemiological survey of adenovirus type 7 circulation among healthy adults in China and in Sierra Leone, West Africa.
Front Public Health
; 11: 1095343, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36815162
10.
Safety and Immunogenicity of Homologous Recombinant Adenovirus Type 5-Vectored COVID-19 Vaccine Booster Dose in Healthy Adults Aged 18-60 Years: a Single-Center, Open-Label Trial.
Infect Dis Ther
; 12(12): 2757-2769, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38038866
11.
Safety and immunogenicity of heterologous boosting with orally aerosolised or intramuscular Ad5-nCoV vaccine and homologous boosting with inactivated vaccines (BBIBP-CorV or CoronaVac) in children and adolescents: a randomised, open-label, parallel-controlled, non-inferiority, single-centre study.
Lancet Respir Med
; 11(8): 698-708, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37209700
12.
Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trial.
Lancet Respir Med
; 11(7): 613-623, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36898400
13.
Boosting with an aerosolized Ad5-nCoV elicited robust immune responses in inactivated COVID-19 vaccines recipients.
Front Immunol
; 14: 1239179, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37868993
14.
Single-dose of a replication-competent adenovirus-vectored vaccine provides sterilizing protection against Rift Valley fever virus challenge.
Front Immunol
; 13: 907675, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36439179
15.
Comparative immunogenicity analysis of intradermal versus intramuscular immunization with a recombinant human adenovirus type 5 vaccine against Ebola virus.
Front Immunol
; 13: 963049, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36119119
16.
Comparative characterization of antibody responses induced by Ad5-vectored spike proteins of emerging SARS-CoV-2 VOCs.
Signal Transduct Target Ther
; 7(1): 257, 2022 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35906201
17.
Broadly neutralizing antibodies against Omicron-included SARS-CoV-2 variants induced by vaccination.
Signal Transduct Target Ther
; 7(1): 139, 2022 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35478188
18.
Proteomic and Metabolomic Characterization of SARS-CoV-2-Infected Cynomolgus Macaque at Early Stage.
Front Immunol
; 13: 954121, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35903092
19.
Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial.
Lancet Infect Dis
; 21(12): 1654-1664, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34324836
20.
A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge.
Nat Commun
; 11(1): 4081, 2020 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32796842